Combined Company Delivers Industry's Most Complete Solution for Health Data Collection and Management Across Life Sciences, ...
Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a muscle-wasting ...
A recent study from Oregon State University estimated that more than 3,500 animal species are at risk of extinction because ...
Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
Decision to invest streamlines transition to frontline AI BENGALURU, India and HERZLIYA, Israel, /PRNewswire/ -- UST, a ...
Dual enrollment can give students a first taste of college, lower the cost of a credential, and accelerate the path to a good first job.
View the full release here: "The operational proximity between TELUS and TELUS Digital has meant that we have our own ...
Enumeration forms to be distributed in all 403 assembly constituencies in Uttar Pradesh as ECI aims at error-free, updated voter list ...
Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is now publicly funded though the Ontario Drug Benefit Program.1 ...
Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA ...
Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...
Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonide) delayed release capsules), has been included ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback